Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Microbiol., 08 August 2025

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fmicb.2025.1672871

This article is part of the Research TopicEmerging Antimicrobials: Sources, Mechanisms of Action, Spectrum of Activity, Combination Antimicrobial Therapy, and Resistance MechanismsView all 42 articles

Correction: Biological activity of secondary metabolites of actinomycetes and their potential sources as antineoplastic drugs: a review

This article is a correction to:

  1. Biological Activity of Secondary Metabolites of Actinomycetes and Their Potential Sources As Antineoplastic Drugs: A Review

    1. Read original article
Sun Rui&#x;Sun Rui1†Guo Fengrui&#x;Guo Fengrui2†Zhang YiningZhang Yining1Shao HongShao Hong1Yang XuewenYang Xuewen1Wang ChangpingWang Changping1Yang Chunjia Yang Chunjia2*
  • 1College of Biology and Agriculture, Jiamusi University, Jiamusi, China
  • 2School of Basic Medicine, Jiamusi University, Jiamusi, China

A Correction on
Biological activity of secondary metabolites of actinomycetes and their potential sources as antineoplastic drugs: a review

by Rui, S., Fengrui, G., Yining, Z., Hong, S., Xuewen, Y., Changping, W., and Chunjia, Y. (2025). Front. Microbiol. 16:1550516. doi: 10.3389/fmicb.2025.1550516

An incorrect number was provided for Heilongjiang Province. The correct number is (2021-KYYWF-0574).

The correct funding statement reads:

The author(s) declare that financial support was received for the research and/or publication of this article. This study was funded by the Basic Scientific Research Business Expenses of Colleges and Universities in Heilongjiang Province (2021-KYYWF-0574).

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: actinomycetes, antitumor, cancer, secondary metabolite, activity

Citation: Rui S, Fengrui G, Yining Z, Hong S, Xuewen Y, Changping W and Chunjia Y (2025) Correction: Biological activity of secondary metabolites of actinomycetes and their potential sources as antineoplastic drugs: a review. Front. Microbiol. 16:1672871. doi: 10.3389/fmicb.2025.1672871

Received: 25 July 2025; Accepted: 28 July 2025;
Published: 08 August 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Rui, Fengrui, Yining, Hong, Xuewen, Changping and Chunjia. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yang Chunjia, eWFuZ2NodW5qaWEyMDA1QDE2My5jb20=

†These authors share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.